Home › Compare › TGRNF vs GBDC

TGRNF vs GBDC: Dividend Comparison 2026

TGRNF yields 4.55% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.74M in total portfolio value
10 years
TGRNF
TGRNF
● Live price
4.55%
Share price
$0.55
Annual div
$0.03
5Y div CAGR
9.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.5K
Annual income
$1,748.22
Full TGRNF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — TGRNF vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTGRNFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TGRNF + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TGRNF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TGRNF
Annual income on $10K today (after 15% tax)
$386.94/yr
After 10yr DRIP, annual income (after tax)
$1,485.99/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, GBDC beats the other by $13,929,387.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TGRNF + GBDC for your $10,000?

TGRNF: 50%GBDC: 50%
100% GBDC50/50100% TGRNF
Portfolio after 10yr
$10.40M
Annual income
$8,195,505.81/yr
Blended yield
78.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

TGRNF
No analyst data
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TGRNF buys
0
GBDC buys
0
No recent congressional trades found for TGRNF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTGRNFGBDC
Forward yield4.55%11.85% ✓
Annual dividend / share$0.03$1.50 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR9.4%51.1% ✓
Portfolio after 10y$32.5K ✓$20.78M
Annual income after 10y$1,748.22$16,389,263.41 ✓
Total dividends collected$10.0K$20.36M ✓
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: TGRNF vs GBDC ($10,000, DRIP)

YearTGRNF PortfolioTGRNF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$11,198$498.01$12,490$1,790.28$1.3K → GBDC
2$12,552$570.18$16,522$3,157.73$4.0K → GBDC
3$14,084$653.46$23,578$5,898.68$9.5K → GBDC
4$15,820$749.67$37,115$11,886.75$21.3K → GBDC
5$17,788$860.93$66,136$26,423.57$48.3K → GBDC
6$20,023$989.77$137,257$66,491.44$117.2K → GBDC
7$22,564$1,139.11$341,734$194,868.54$319.2K → GBDC
8$25,456$1,312.45$1,050,788$685,133.02$1.03M → GBDC
9$28,751$1,513.87$4,099,314$2,974,971.01$4.07M → GBDC
10$32,512$1,748.22$20,775,530$16,389,263.41$20.74M → GBDC

TGRNF vs GBDC: Complete Analysis 2026

TGRNF — Stock

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.

Full TGRNF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this TGRNF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TGRNF vs SCHDTGRNF vs JEPITGRNF vs OTGRNF vs KOTGRNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.